GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Main Class | Sub Class | LM ID | Common Name | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass ▲ | Formula |
|---|---|---|---|---|---|---|---|---|---|
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(d16:1(4E)(15Me)/22:0(21Me)(2OH)
|
799.653734
|
C46H89NO9
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(t16:0(15Me)/22:0(2OH[R]))
|
803.648649
|
C45H89NO10
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(t17:0(16Me)/21:0(2OH[R]))
|
803.648649
|
C45H89NO10
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(t15:0(14Me)/23:0(2OH[R]))
|
803.648649
|
C45H89NO10
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
HexCer(t17:0/22:0(2OH))
|
803.648649
|
C45H89NO10
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
LacCer(d18:1/12:0)
|
805.555144
|
C42H79NO13
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
LacCer(d14:1/16:0)
|
805.555144
|
C42H79NO13
|
|||||
|
Acidic glycosphingolipids
|
Sulfoglycosphingolipids (sulfatides)
|
(3'-sulfo)Galbeta-Cer(d18:1/18:0)
|
807.553036
|
C42H81NO11S
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
Oreacerebroside E
|
809.638084
|
C47H87NO9
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
Oreacerebroside B
|
809.638084
|
C47H87NO9
|
Displaying entries 171 - 180 of 3908 in total
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
